European Equities Traded in US as ADRs Slump in Thursday Trading

MT Newswires Live
Mar 12

European equities traded in the US as American depositary receipts slumped late Thursday morning with the S&P Europe Select ADR Index declining 1.9% to 1,723.21.

From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and telecommunications company Nokia (NOK), which climbed 6.4% and 3.5%, respectively. They were followed by 3D printer company Materialise (MTLS) and petroleum refiner Equinor (EQNR), which advanced 3.4% and 2.3%, respectively.

The decliners from continental Europe were led by lender Banco Bilbao Vizcaya Argentaria (BBVA) and biopharmaceutical company Cellectis (CLLS), which dropped 6% and 5.5%, respectively. They were followed by lenders Banco Santander (SAN) and ING (ING), which lost 4.1% and 3.9%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX) and oil and gas company BP (BP), which rose 1.9% and 1.3%, respectively. They were followed by utility company National Grid (NGG) and oil and gas company Shell (SHEL), which were up 1.2% and 1.1%, respectively.

The decliners from the UK and Ireland were led by lender Barclays (BCS) and cruise line operator Carnival (CUK), which fell 6.3% and 6.1%, respectively. They were followed by lender HSBC (HSBC) and biotech company Autolus Therapeutics (AUTL), which were down 4.7% and 4.2%, respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10